Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Changli Peng"'
Autor:
Liangrong Shi, Junjun Wang, Nianhua Ding, Yi Zhang, Yibei Zhu, Shunli Dong, Xiaohui Wang, Changli Peng, Chunhui Zhou, Ledu Zhou, Xiaodong Li, Hongbing Shi, Wei Wu, Xueyin Long, Changping Wu, Weihua Liao
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-13 (2019)
Radiofrequency ablation is used to treat metastatic colorectal cancer. In this study, the authors show that incomplete ablation of tumours results in metastases and show in mouse models that the chemokine CCL2 recruits myeloid cells to the partially
Externí odkaz:
https://doaj.org/article/7ee06799e14541969149a6f48d4cd21b
Autor:
Changli Peng, Bin Xu, Juxiong Xiao, Chunhui Zhou, Xiaodong Li, Hongbing Shi, Weiguang Qiang, Tianming Wang, Jiemin Zhao, Fei Liu, Gang Li, Haiping Li, Changyong Chen, Liangrong Shi
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
AimTo evaluate the efficacy of hepatic artery infusion (HAI) of floxuridine (FUDR) in combination with systemic chemotherapy in patients with pancreatic cancer liver metastases (PCLM).Patients and MethodsWe retrospectively collected clinical data of
Externí odkaz:
https://doaj.org/article/d65dec81a4d34de5b78773f2b4e54bbc
Autor:
Chunhui Zhou1, Changli Peng1, Fei Liu1, Juxiong Xiao1, Gang Li1, Changyong Chen1, Liangrong Shi1, Haiping Li1 lihaiping518@sina.com
Publikováno v:
Journal of Cancer Research & Therapeutics. Dec2023, Vol. 19 Issue 6, p1575-1581. 7p.
Autor:
Sai Li, Yong Li, Chunhui Zhou, Haiping Li, Changyong Chen, Changli Peng, Tianming Wang, Fei Liu, Juxiong Xiao, Liangrong Shi
Publikováno v:
CardioVascular and Interventional Radiology.
Autor:
Chunhui Zhou, Yan Li, Jiaping Li, Botian Song, Hanfeng Li, Bin Liang, Shanzhi Gu, Haiping Li, Changyong Chen, Sai Li, Changli Peng, Fei Liu, Juxiong Xiao, Xueying Long, Ping Li, Zhengping Xiong, Xiaoping Yi, Weihua Liao, Liangrong Shi
Publikováno v:
Clinical Cancer Research.
Purpose: To assess the safety and efficacy of local ablation plus PD-1 inhibitor toripalimab in previously treated unresectable hepatocellular carcinoma (HCC). Patients and Methods: In the multicenter, two-stage, and randomized phase 1/2 trial, patie
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 36:211-219
Background: Hepatocellular carcinoma (HCC) is associated with high morbidity and mortality and has become the most frequently diagnosed liver cancer globally. Long noncoding RNAs have been widely s...
Publikováno v:
International Journal of Hydrogen Energy. 46:666-675
The fast release of hydrogen from borohydride is highly desired for a fuel cell system. However, the generation of hydrogen from borohydride is limited by the low activity and low stability of the catalyst. Herein, a highly active catalyst is synthes
Publikováno v:
Clinical & Experimental Metastasis
To evaluate the benefits and risks of hepatic artery infusion (HAI) gemcitabine and floxuridine (FUDR) in patients with nasopharyngeal carcinoma liver metastases. HAI catheter systems were implanted under the guide of digital subtract angiography (DS